The ROE as of November 2024 (TTM) for Travere Therapeutics, Inc. (TVTX) is -541.59%

According to Travere Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -541.59%. This represents a change of 321.92% compared to the average of -128.36% of the last 4 quarters.

Travere Therapeutics, Inc. (TVTX) Historical ROE (quarterly & annually)

How has TVTX ROE performed in the past?

The mean historical ROE of Travere Therapeutics, Inc. over the last ten years is -64.27%. The current -541.59% ROE has changed 742.68% with respect to the historical average. Over the past ten years (40 quarters), TVTX's ROE was at its highest in in the September 2024 quarter at 179.98%. The ROE was at its lowest in in the June 2024 quarter at -464.84%.

Travere Therapeutics, Inc. (TVTX) ROE by Quarter and Year

Discovering the peaks and valleys of Travere Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Travere Therapeutics, Inc. (TVTX) Average ROE

How has TVTX ROE performed in the past?

The current ROE of Travere Therapeutics, Inc. (TVTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Travere Therapeutics, Inc. (TVTX) ROE vs. Peers

How is TVTX’s ROE compared to its peers?

Travere Therapeutics, Inc.’s ROE is less than DICE Therapeutics, Inc. (56.07%), less than Cytokinetics, Incorporated (335.19%), greater than Ventyx Biosciences, Inc. (-54.94%), greater than Cogent Biosciences, Inc. (-70.85%), greater than Nuvalent, Inc. (-28.63%), greater than Cerevel Therapeutics Holdings, Inc. (-98.94%), greater than Structure Therapeutics Inc. (-16.40%), greater than Revolution Medicines, Inc. (-33.67%), greater than Akero Therapeutics, Inc. (-32.52%), greater than Avidity Biosciences, Inc. (-27.66%), less than Protagonist Therapeutics, Inc. (34.68%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than IDEAYA Biosciences, Inc. (-19.42%), greater than AnaptysBio, Inc. (-287.94%), greater than MeiraGTx Holdings plc (-80.95%), greater than Keros Therapeutics, Inc. (-41.74%), greater than Homology Medicines, Inc. (-100.91%), greater than Legend Biotech Corporation (-29.69%), greater than Vaxcyte, Inc. (-23.53%), greater than Apellis Pharmaceuticals, Inc. (-103.92%),

Build a custom stock screener for Travere Therapeutics, Inc. (TVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Travere Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Travere Therapeutics, Inc. (TVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Travere Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.